CI

At a glance

ClinicalIndex Comparison Record
N/AUnknown· 3 target
Drug / intervention
Device implantationprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04965727
NCT04965727N/AUnknown

Deep Brain Stimulation of the Lateral Hypothalamus to Augment Motor Function of Patients With Spinal Cord Injury

Jocelyne Bloch·interventional·Posted Jul 16, 2021·Updated Sep 6, 2023

In Brief

A clinical study evaluating Device implantation for Deep Brain Stimulation and Neuro: Spinal Cord Injury. Targeting 3 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate safety of Deep Brain Stimulation (DBS) of the lateral hypothalamus (LH) and whether the use of DBS can increase motor performance in patients with chronic spinal cord injury (SCI). The hypothesis, based on preclinical findings, is that DBS of the lateral hypothalamus can acutely augment leg motor function after SCI, and that the use of lateral hypothalamus DBS can be an adjunct during rehabilitation to promote recovery and long-term neuroplasticity.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesSwitzerland

Timeline

N/AUnknownOverdue
20222023202420252026
First PostedJul 16, 2021
Enrollment StartJun 14, 2021
Primary CompletionJan 1, 2026
TodayJul 1, 2026
Enrollment to primary: 4.5 yearsPosted 5.0 years ago

Interventions

Device implantationprocedure

The intervention involves the insertion of lead electrodes (Medtronic SenSight Directional Lead) in the right and left lateral hypothalamus through craniotomy and an implantable pulse generator (Medtronic Model B35200 Percept™ PC) in the upper part of the pectoralis major (under the clavicle).